Clinical Trial Update: Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated cediranib in combination with lomustine for recurrent glioblastoma; the study has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Cediranib (Cediranib)
• Lomustine (Lomustine)

Snippet

Sponsor: AstraZeneca | Conditions: Recurrent Glioblastoma | Phase 3 | Status: COMPLETED | Results posted: 2012-12-21